The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Ethical challenges with CAR T slot allocation with idecabtagene vicleucel manufacturing access.
 
Taxiarchis Kourelis
No Relationships to Disclose
 
Radhika Bansal
No Relationships to Disclose
 
Krina K. Patel
Consulting or Advisory Role - Arcellx; Bristol-Myers Squibb; Celgene; Janssen; Karyopharm Therapeutics; Pfizer
Research Funding - Abbvie/Genentech; Allogene Therapeutics; Celgene/Bristol-Myers Squibb; Cellectis; Janssen; Nektar; poseida therapeutics; Precision Biosciences; Takeda
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Jesus G. Berdeja
Consulting or Advisory Role - Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); crispr therapeutics (Inst); Janssen (Inst); Kite, a Gilead company (Inst); Legend Biotech (Inst); Secura Bio (Inst); Takeda (Inst)
Research Funding - Abbvie (Inst); Acetylon Pharmaceuticals (Inst); Amgen (Inst); Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celularity (Inst); crispr therapeutics (Inst); EMD Serono (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Ichnos Sciences (Inst); Incyte (Inst); Janssen (Inst); Lilly (Inst); Novartis (Inst); poseida therapeutics (Inst); Sanofi (Inst); Takeda (Inst); Teva (Inst)
 
Noopur S. Raje
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Caribou Biosciences; Celgene; Immuneel Therapeutics; Janssen Oncology; Merck; Pfizer; Takeda
Research Funding - Bluebird Bio (Inst)
 
Melissa Alsina
Honoraria - Janssen
Consulting or Advisory Role - BMS; Janssen Oncology
Speakers' Bureau - Janssen Oncology
 
Adam D. Cohen
Consulting or Advisory Role - AstraZeneca; Bristol Meyers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Novartis; Oncopeptides; Roche/Genentech; Seagen; Takeda
Research Funding - GlaxoSmithKline (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Patents related to CAR T cells and biomarkers of Cytokine Release Syndrome
Expert Testimony - Janssen Oncology
Travel, Accommodations, Expenses - Celgene; GlaxoSmithKline; Janssen Oncology; Janssen Oncology; Takeda
 
David Samuel DiCapua Siegel
Stock and Other Ownership Interests - Celularity
Consulting or Advisory Role - Bristol-Myers Squibb; Celularity; Janssen Oncology; Karyopharm Therapeutics; Neximmune; Takeda
Speakers' Bureau - Bristol-Myers Squibb; GlaxoSmithKline; Janssen Oncology; Takeda
 
Sham Mailankody
Honoraria - OncLive/MJH Life Sciences; Physicans' Education Resource; Plexus
Consulting or Advisory Role - Janssen Oncology; Legend Biotech
Research Funding - Alimera Sciences (Inst); Bristol-Myers Squibb (Inst); Fate Therapeutics; Fate Therapeutics; Janssen Oncology (Inst); Juno Therapeutics (Inst); Takeda (Inst)
 
Myo Htut
Consulting or Advisory Role - Millennium
Research Funding - BMS (Inst); Judy and Bernard Briskin Center for Multiple Myeloma Research (Inst)
Travel, Accommodations, Expenses - Millennium
 
Surbhi Sidana
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; Janssen; Magenta Therapeutics; Oncopeptides; Sanofi
Research Funding - Allogene Therapeutics (Inst); Bristol-Myers Squibb/Celgene (Inst); Janssen (Inst); Magenta Therapeutics (Inst)
 
Sarah A. Holstein
Consulting or Advisory Role - Celgene; Genentech; GlaxoSmithKline; Janssen Oncology; Oncopeptides; Sanofi; Secura Bio; Takeda
Research Funding - Oncopeptides
 
Andrew Cowan
Stock and Other Ownership Interests - Doximity
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb/Celgene/Juno; Cellectar; Doximity; Janssen; Sanofi; Secura Bio
Research Funding - Abbvie (Inst); Adaptive Biotechnologies (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Harpoon therapeutics (Inst); Janssen (Inst); Nektar (Inst)
 
Nina Shah
Consulting or Advisory Role - Amgen; CareDX; CSL Behring; Genentech/Abbvie; GlaxoSmithKline; Indapta Therapeutics; Karyopharm Therapeutics; Kite, a Gilead company; Oncopeptides; Sanofi
Research Funding - Bluebird Bio; Celgene; Cellectis; Janssen; Nektar; poseida therapeutics; Precision Biosciences; Sutro biopharma; Teneobio
 
Peter Leif Bergsagel
Consulting or Advisory Role - Celgene; GlaxoSmithKline; Isis Pharmaceuticals; Janssen; Janssen; Mundipharma; Novartis; Novartis (I); Pfizer (I)
Patents, Royalties, Other Intellectual Property - Mouse model of multiple myeloma
Travel, Accommodations, Expenses - Celgene
 
Sikander Ailawadhi
Honoraria - Amgen (Inst); Amgen (Inst); AstraZeneca (Inst); BMS (Inst); Janssen (Inst)
Consulting or Advisory Role - Beigene; Celgene; GlaxoSmithKline; Oncopeptides; Sanofi; Takeda
Research Funding - Amgen (Inst); BMS (Inst); Cellectar (Inst); Janssen Biotech (Inst); MedImmune (Inst); Pharmacyclics (Inst); Phosplatin Therapeutics (Inst); Xencor (Inst)
 
Yi Lin
Consulting or Advisory Role - Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Gamida Cell (Inst); Janssen Oncology (Inst); Juno Therapeutics (Inst); Kite/Gilead (Inst); Legend Biotech (Inst); Novartis (Inst); Pfizer (Inst); Sorrento Therapeutics (Inst); Vineti (Inst)
Research Funding - Bluebird Bio (Inst); Boston Scientific (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Janssen Oncology (Inst); Kite/Gilead (Inst); Merck (Inst); Takeda (Inst)